e-learning
resources
Munich 2014
Monday, 08.09.2014
Healthcare, prevention and adjunctive treatments in respiratory infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Co-existent rheumatoid arthritis and non-cystic fibrosis bronchiectasis: Evidence for more severe pulmonary disease using the bronchiectasis severity index (BSI)
J. Aust, J. Davison, E. Perry, P. Eggleton, D. Hutchinson, J. Chalmers, C. Kelly, A. De Soyza (Newcastle upon Tyne, Gateshead, Exeter, Truro, Dundee, Barnstable, United Kingdom)
Source:
International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections
Session:
Healthcare, prevention and adjunctive treatments in respiratory infections
Session type:
Thematic Poster Session
Number:
2519
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Aust, J. Davison, E. Perry, P. Eggleton, D. Hutchinson, J. Chalmers, C. Kelly, A. De Soyza (Newcastle upon Tyne, Gateshead, Exeter, Truro, Dundee, Barnstable, United Kingdom). Co-existent rheumatoid arthritis and non-cystic fibrosis bronchiectasis: Evidence for more severe pulmonary disease using the bronchiectasis severity index (BSI). Eur Respir J 2014; 44: Suppl. 58, 2519
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
ERS statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trials
Imaging of complicated pneumonia: what is new?
Related content which might interest you:
Rheumatoid arthritis and bronchiectasis: A multicentre study assessing pulmonary disease severity using the bronchiectasis severity index (BSI)
Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections
Year: 2014
Is etiology of non-cystic fibrosis bronchiectasis (NCFBE) a risk factor for severe exacerbation?
Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections
Year: 2014
Impact of co-morbidities on disease severity and risk of mortality in non-cystic fibrosis bronchiectasis
Source: International Congress 2015 – Adult bronchiectasis: risk factors and future perspectives
Year: 2015
Non-pulmonary comorbidities in idiopathic pulmonary fibrosis
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015
Respiratory infections in patients with idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2009 - Idiopathic pulmonary fibrosis: concepts and mechanisms
Year: 2009
Rheumatoid arthritis and comorbid chronic obstructive or interstitial pulmonary diseases: Prevalence in a population-based cohort
Source: International Congress 2016 – Burden of respiratory diseases: from environmental aspects to healthcare consumption
Year: 2016
Comorbidities in patients with the combined pulmonary fibrosis and emphysema syndrome (CPFE)
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015
Comparative analysis of the predictive utility of clinical disease severity scores for non-cystic fibrosis bronchiectasis
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014
Factors contributing to severe pneumonia in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections
Year: 2014
Comparison between patients with idiopathic pulmonary fibrosis and patients with pulmonary involvement of the usual interstitial pneumonia pattern that preceded the onset of rheumatoid arthritis
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014
Positive microbiology findings in non-cystic fibrosis bronchiectasis and co-morbidities
Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections
Year: 2016
Exacerbations in non-cystic fibrosis bronchiectasis
Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections
Year: 2014
DLCO predicts disease severity and mortality in patients with non-cystic fibrosis bronchiectasis
Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook
Year: 2015
Relationship between chronic dyspnoea and indices of disease severity in idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2001; 18: Suppl. 33, 150s
Year: 2001
Tuberculosis in patients with idiopathic pulmonary fibrosis
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015
Pulmonary nocardiosis (PN) complicating chronic pulmonary diseases
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014
Chronic obstructive pulmonary disease exacerbations: Impact of the GOLD stage or the presence of bronchiectasis on sputum microbiology
Source: Annual Congress 2013 –Research questions on how viruses affect the respiratory system
Year: 2013
Course of disease and cause of death in patients with idiopathic pulmonary fibrosis in Eastern Finland
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015
Study of inflammatory markers and BODE index in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
Etiologies of exacerbations of the chronic obstructive pulmonary disease in Tunisia
Source: Annual Congress 2013 –Lung infections: a clinical point of view
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept